This article refers to:
Oronsky B, Paulmurugan R, Foygel K, et al. RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trials. Expert Opin Investig Drugs, 2017 Jan;26(1):109–119. http://dx.doi.org/10.1080/13543784.2017.1268600
When the above article was first published online, one of the author’s name was misspelt as Corey A. Carterg. The correct author name is Corey A. Carter.
Taylor & Francis apologises for this error.